Pulmonary Disease, Chronic Obstructive Clinical Trial
— COPDOfficial title:
Effects of High-repetitive Single Limb Training on Exercise Capacity and Quality of Life in Patients With COPD Compared to a Control Group - A Prospective, Single Blind, Randomized Controlled Multicenter Trial
Verified date | June 2012 |
Source | Umeå University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Sweden: Regional Ethical Review Board |
Study type | Interventional |
The chronic airflow limitation in chronic obstructive pulmonary disease (COPD) patients resulting in increased dyspnea during physical activity restricts many COPD patients ability to perform exercises in general and whole-body exercises in particular. Single limb training performed as one-legged cycling has been shown effective in patients with COPD. This exercise regime results in less stress on the ventilatory system as training is executed using a simultaneously smaller muscle mass. However, the positive physiological effects of exercise training only occur in the involved muscle(s). To be of benefit for patients daily life, all relevant muscles should be included in exercise training. The aim of the current randomized controlled multicenter trial (RCT) is to determine the effects of high-repetitive single limb exercises (HRSLE) in combination with COPD specific patient education, compared to the COPD specific patient education alone in patients with moderate to very severe (stage II-IV) COPD.
Status | Completed |
Enrollment | 44 |
Est. completion date | June 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 40 Years and older |
Eligibility |
Inclusion Criteria: 1. Adults 40 years and above. 2. Stable (no exacerbations within 4 weeks before start of baseline testing) moderate to very severe COPD, stage II-IV, according to GOLD criteria i.e. Forced expiratory volume in one second (FEV1)/ forced vital capacity (FVC) < 0.70, FEV1 < 80% predicted. 3. Ex-smoker. 4. Stable medical treatment (no changes < 4 weeks before start of baseline testing). 5. Living less than 60 km from training facility. Exclusion Criteria: 1. Musculoskeletal, rheumatic, cardiac or neurological disorders that might affect the exercise performance in training and tests. 2. Previous lung surgery. 3. Acute exacerbations of COPD that require a change in pharmacological management within four weeks preceding the start of the intervention 4. Long-term oxygen treatment. 5. Participated in organized exercise training, > 2 times a week, within 6 months before start of intervention. 6. Body mass index (BMI) < 18 kg/m2. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Huddinge University Hospital | Huddinge | |
Sweden | Umeå University Hospital | Umeå |
Lead Sponsor | Collaborator |
---|---|
Umeå University |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Quality of life | The Swedish Self-Administered Standardized version of the Chronic Respiratory Disease Questionnaire (CRQ-SAS) will be used as primary outcome measure to asses quality of life | Before single limb exercise regime and on completion (at 8 weeks) | No |
Primary | Functional lower extremity muscular endurance | To asses muscular endurance in the lower extremity the 6-minute walk test will be used as primary outcome measure. | Before single limb exercise regime and on completion (at 8 weeks) | No |
Primary | Upper extremity muscular endurance | The 6-minute ring and pegboard test will be used as primary outcome measure for upper extremity muscular endurance | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Isokinetic maximal muscle strength | Maximal muscle strength in both upper and lower extremity will be evaluated with an isokinetic dynamometer | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Upper extremity muscular endurance | The Unsupported Upper Limb Exercise test will be used as secondary outcome measure for upper extremtiy muscular endurance | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Isokinetic muscular endurance capacity | Endurance capacity in both upper and lower extremity will be evaluated with an isokinetic dynamometer | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Self-efficacy | Self-efficacy will be evaluated with the exercise self-efficacy scale, and the self-efficacy for walking questionnaire | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Anxiety and Depression | Anxiety and Depression will be evaluated with the hospital anxiety and depression scale (HADs) | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Relationship between muscle fatigue and dyspnea in the different exercise tests | Muscle fatigue and dyspnea will be measured using the BORG CR10 scale during all exercise tests before the start of the study and on completion 8 weeks later. The relationship between ratings of muscle fatigue between tests, dyspnea between tests and the relationship between muscle fatigue rating and dyspnea rating between exercise tests will be investigated. | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Develop a strategy to optimize resistance for each involved movement within an exercise regimen | The exercises used within the intervention group is performed with elastic resistance. How much the elastic band is stretched for the different exercises is determined by a literature search investigation the strenght relationship between the muscles/movements used in the study. During the study each participant in the intervention group will rate muscle fatigue and dyspnea after each exercise during alla exercise sessions. These rating will be used to develop a strategy to optimize resistance for each involved movement within an exercise regimen | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Develop a strategy to minimize attempts needed to determine a multiple repetition resistance using elastic bands | 55% of the isokinetic peak value obtained during baseline tests will be used to anticipate the 25RM load when using elastic resistance in an attempt to minimize the attempts needed to achieve 25RM. | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Determine if this exercise regimen is feasible and safe in stage II-IV COPD patients | Feasibility will be evaluated through number of participants attendance, adherence and number of participants developing any side effects or injuries during each training session. In addition, compliance to the different parts of the exercise regimen will be evaluated with a standardized questionnaire by both study participants and physiotherapists leading interventions. | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Identify if there are any sex related differences in exercise training effects | Statistical analyzes will be used to identify if there are any sex related differences in exercise training effects between male and female patients with COPD | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Quality-of-life | The clinical COPD questionnaire (CCQ) and the SF-36 scale will be used as secondary outcome measures for Quality-of-life | Before single limb exercise regime and on completion (at 8 weeks) | No |
Secondary | Exercise capacity | A constant work rate test investigating the effects on endurance time, ventilatory response, perceived dyspnea and leg fatigue during submaximal cycle test. | Before single limb exercise regime and on completion (at 8 weeks) | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|